文献速递消化、代谢与肾脏急症

格拉斯哥-布拉奇福德评分、改良格拉斯哥-布拉奇福德评分与CANUKA评分在急诊科识别上消化道出血低危患者的外部验证:一项回顾性队列研究

External validation of Glasgow-Blatchford, modified Glasgow-Blatchford and CANUKA scores to identify low-risk patients with upper gastrointestinal bleeding in emergency departments: a retrospective cohort study.
PubMed 文献 · Emerg Med J · 2023-04-26
一句话结论单中心回顾性队列显示,GBS≤1或CANUKA≤2似乎可安全识别上消化道出血后死亡或需干预风险低的患者。

该单中心回顾性研究纳入2016年1月至2018年12月法国巴黎圣安托万医院急诊科386例疑似上消化道出血患者,评估GBS、mGBS与CANUKA评分识别低危患者的能力。GBS≤1、mGBS=0、CANUKA≤2分别将24.9%、18.2%、18.9%患者归为低危,其需干预比例分别为2.2%、4.6%、0%,各评分低危组均无死亡,所有评分敏感性和阴性预测值均高。作者认为GBS≤1或CANUKA≤2似乎可安全用于识别低危患者。

要点

  • 386例疑似上消化道出血患者中,GBS≤1、mGBS=0、CANUKA≤2分别识别24.9%、18.2%、18.9%为低危。
  • GBS≤1低危组需干预(7天内输血、内镜止血或再出血)比例为2.2%,mGBS=0组为4.6%,CANUKA≤2组为0%。
  • 无论使用哪种评分,被归为低危的患者均无死亡。
  • 所有评分均具有高敏感性和阴性预测值,作者认为GBS≤1或CANUKA≤2似乎可安全识别低危患者。

适用人群与场景

  • 2016年1月至2018年12月就诊于法国巴黎圣安托万医院急诊科的疑似上消化道出血患者,共386例,中位年龄60岁(38-78),男性65.3%(n=252),住院率60%(n=233)。

诊断标准与关键阈值

  • 低危阈值:GBS≤1、mGBS=0、CANUKA≤2。
  • 需干预定义为7天内需要输血、内镜止血或再出血。

研究设计与关键结果

  • 单中心回顾性研究,纳入386例疑似上消化道出血患者,评估GBS、mGBS与CANUKA评分对低危患者的识别能力。
  • GBS≤1、mGBS=0、CANUKA≤2分别将24.9%、18.2%、18.9%的患者归为低危。
  • 低危组需干预比例:GBS≤1组2.2%,mGBS=0组4.6%,CANUKA≤2组0%。
  • 无论使用哪种评分,低危组均无死亡;所有评分均具有高敏感性和阴性预测值。

证据类型、等级与局限

  • 证据类型:单中心回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在因上消化道出血就诊于急诊科的患者中,使用GBS≤1或CANUKA≤2似乎可安全识别死亡或需干预风险低的患者。
  • mGBS=0在本文低危组中需干预比例为4.6%,高于GBS≤1组的2.2%和CANUKA≤2组的0%。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Upper gastrointestinal bleeding (UGIB) is a medical emergency with an approximate mortality of 10%, which results in a high hospitalisation rate. The Glasgow-Blatchford score (GBS) is recommended to identify low-risk patients who can be discharged from the emergency department (ED). A modified GBS (mGBS) and CANUKA score have recently been proposed but have not been well studied. The aim of this study was to assess whether the use of GBS, mGBS or CANUKA score could identify patients at low risk of death or need for intervention.

METHODS: A single-centre retrospective study was performed including patients with suspected UGIB visiting the ED of Saint-Antoine hospital (Paris, France) from January 2016 to December 2018. Demographic and medical data needed to calculate GBS and CANUKA were collected, as well as outcomes data. Need for intervention was defined as the need for blood transfusion, endoscopic haemostasis or rebleeding within 7 days. In-hospital mortality was also collected. Sensitivity, specificity and predictive values were measured for the score thresholds of interest.

RESULTS: A total of 386 patients were included. Median age was 60 years (38-78), 65.3% (n=252) were male and 60% (n=233) were hospitalised. A GBS≤1, mGBS=0 and CANUKA≤2 categorised 24.9%, 18.2% and 18.9% of patients as low risk, respectively. There was a need for intervention in 2.2%, 4.6% and 0% of those patients categorised as low risk by GBS, mGBS and CANUKA, respectively. No deaths occurred in the patients identified as low risk, regardless of the score used. All scores had a high sensitivity and negative predictive value.

CONCLUSIONS: In patients with UGIB, the use of a GBS≤1 or CANUKA score ≤2 appears to be safe for identifying patients at low risk of death or need for intervention.

来源:Emerg Med J,查看原文。版权归原作者所有。

参考来源

  1. Pognonec C, Dirhoussi Z, Cury N, et al. External validation of Glasgow-Blatchford, modified Glasgow-Blatchford and CANUKA scores to identify low-risk patients with upper gastrointestinal bleeding in emergency departments: a retrospective cohort study. Emerg Med J. 2023. PMID: 37185303. doi:10.1136/emermed-2022-213052

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。